Marker Therapeutics, Inc. (MRKR)

NASDAQ: MRKR · Real-Time Price · USD

1.140

+0.030 (2.70%)

At close: Aug 14, 2026, 4:00 PM EDT

1.130

-0.010 (-0.88%)

After-hours: Aug 14, 2026, 4:10 PM EDT

Marker Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	3.55	3.55	6.59	3.31	3.51	1.24
Revenue Growth	-33.67%	-46.19%	99.06%	-5.76%	182.96%	166.01%
Cost of Revenue	11.51	11.8	13.47	10.42	11.97	27.79
Gross Profit	-7.96	-8.25	-6.88	-7.11	-8.45	-26.55
Selling, General & Admin	4.05	4.18	4.24	7.48	11.34	12.92
Operating Expenses	4.05	4.18	4.24	7.48	11.34	12.92
Operating Income	-12.01	-12.44	-11.12	-14.58	-19.79	-39.48
Interest & Investment Income	0.56	0.59	0.44	0.54	0.25	0.01
Other Non Operating Income (Expenses)	0.53	0.12	-	-	-	-
EBT Excluding Unusual Items	-10.91	-11.73	-10.68	-14.04	-19.54	-39.47
Other Unusual Items	-	-0.45	-	-	-0.23	-2.41
Pretax Income	-10.91	-12.18	-10.68	-14.04	-19.78	-41.88
Income Tax Expense	-0.02	-0.02	0.05	0	-	-
Earnings From Continuing Operations	-10.9	-12.16	-10.73	-14.05	-19.78	-41.88
Earnings From Discontinued Operations	-	-	-	5.81	-10.15	-
Net Income	-10.9	-12.16	-10.73	-8.24	-29.93	-41.88
Net Income to Common	-10.9	-12.16	-10.73	-8.24	-29.93	-41.88
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	17	15	9	9	8	8
Shares Outstanding (Diluted)	17	15	9	9	8	8
Shares Change	82.16%	70.49%	1.94%	5.49%	9.16%	62.64%
EPS (Basic)	-0.63	-0.79	-1.19	-0.94	-3.58	-5.47
EPS (Diluted)	-0.63	-0.79	-1.19	-0.94	-3.59	-5.47
EPS Growth	-	-	-	-	-	-
Free Cash Flow	-7.92	-12.01	-10.91	-16.44	-26.97	-30.41
Free Cash Flow Per Share	-0.46	-0.79	-1.22	-1.87	-3.23	-3.98
Gross Margin	-224.43%	-232.68%	-104.33%	-214.60%	-240.64%	-
Operating Margin	-338.49%	-350.67%	-168.69%	-440.37%	-563.28%	-3179.32%
Profit Margin	-307.24%	-342.96%	-162.82%	-248.76%	-851.87%	-3372.68%
Free Cash Flow Margin	-223.27%	-338.74%	-165.53%	-496.51%	-767.66%	-2449.11%
EBITDA	-	-	-	-11.79	-17	-37.33
D&A For EBITDA	-	-	-	2.79	2.79	2.15
EBIT	-12.01	-12.44	-11.12	-14.58	-19.79	-39.48
EBIT Margin	-	-	-168.69%	-	-	-
Revenue as Reported	3.55	3.55	6.59	3.31	3.51	1.24

SEC Filings: 10-K · 10-Q